Montu Owned Alternaleaf Are The Main Company Called Out Re Cannabis Prescribing Issues In Australia In Latest Press Article | Cannabis Law Report | Where to order Skittles Moonrock online

Learn where to buy CBD online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

Cannabiz Australia

Perplexity tells us

Montu Group Pty Ltd, trading as Montu Cannabis Australia, is primarily owned by MG Invest Limited, a Hong Kong–incorporated entity that holds approximately 83.7% of issued shares as of October 2024. The remaining 16.3% of shares are distributed among approximately 2,350 crowd-sourced funding (CSF) shareholders, with none of these minority holders owning more than 1% individually.

The company’s board of directors consists of:

• Christopher Strauch: Founder, Managing Director, and representative nominated by MG Invest.

• Rhys Staley: Director.

Christopher Strauch is also noted as the sole director of Alternaleaf, a wholly owned subsidiary of Montu.

Montu held a shareholder meeting in August 2024 concerning a selective share buy-back, designed to increase MG Invest’s ownership and potentially enable compulsory acquisition of the minority interests; if fully enacted, MG Invest’s holding could rise to approximately 93.2%. This buy-back and its process were scrutinized by the Australian Takeovers Panel amid concerns regarding the implications for minority shareholders.

• Ownership structure: Dominated by MG Invest (83.7%), minority CSF shareholders (16.3%).

• Board: Two directors — Christopher Strauch (Managing Director/founder) and Rhys Staley.

There are no other significant single shareholders or board members reported in the current explicit records

This is what Alternaleaf say about themselves

We’re Australia’s leading alternative healthcare clinic, and our telehealth services could help you manage pain, improve sleep, reduce stress & more^1,2. With over 120 Ahpra-listed doctors and nurses on our team, we bring qualified advice to your fingertips. If you’ve got a phone (or any device with Wi-Fi), you’ve got access to personalised alternative care.

Read more at

https://www.alternaleaf.com.au/about-us?_sp=413e618c-5481-4b4b-96ff-584b453f7277.1753950637269

Here’s a profile of Strauch by Inspirepreneur magazine that quite honestly reads as though the Montu PR  just emailed them the entire article for publication

When it comes to leaders revolutionising the world of alternative healthcare, few names stand out like Christopher Strauch. As the Founder and Managing Director of Montu, Christopher has redefined the potential of healthtech, establishing Montu as the largest company of its kind outside North America. Through innovative technology and patient-centric care, Montu is transforming lives and paving the way for a more accessible healthcare future.

Montu’s Mission in Alternative Healthcare

Montu, an Australian healthtech company specialising in medicinal cannabis, provides innovative alternatives to conventional medication. By focusing on chronic conditions such as pain, anxiety, and insomnia, Montu has built a robust platform that combines patient-centric care with streamlined services.

Through Alternaleaf, Montu’s telehealth clinic, the company conducts over 150,000 patient consultations annually. These consultations connect patients with qualified practitioners who are trained to recommend tailored medicinal cannabis treatments. To complete the ecosystem, their Leafio platform delivers medications seamlessly through an efficient distribution network, while SAGED offers accredited education for healthcare professionals to stay informed about the latest treatment options.

Montu truly integrates every step of the patient’s healthcare journey, ensuring accessibility, affordability, and effective care at every stage.

Achievements That Redefine Healthtech

Christopher Strauch’s leadership and Montu’s innovative approach have continually earned industry recognition. Montu has been named the fastest-growing tech company in Australia for two consecutive years (2022 and 2023) by Deloitte’s Tech Fast 50—a rare feat. The company achieved an extraordinary growth rate of 9,616% over the past three years, eclipsing previous winners such as Afterpay and Atlassian.

But the accolades don’t stop there. Montu’s recognition as Australia’s Top Startup by LinkedIn in 2024 further validates its commitment to innovation and patient care. Ranked fifth in 2023, Montu’s climb to the top is no accident—it’s a testament to the strategic vision and unwavering focus of its leadership team.

Redefining Patient-Centric Healthcare

At its core, Montu thrives on a philosophy of patient-centred care, focusing on improving the affordability and accessibility of medicinal cannabis. By leveraging advanced telehealth platforms, the company empowers patients with tailored solutions that genuinely make a difference in their quality of life.

A key differentiator is the company’s ability to provide holistic care through its tech-based ecosystem. Alternaleaf remains the leading cannabis clinic in the country, offering quick and effective consultations. Meanwhile, Leafio and uMeds ensure rapid medication delivery, eliminating unnecessary delays. Additionally, SAGED provides healthcare practitioners with cutting-edge knowledge, fostering confidence and expertise in treating patients with alternative therapies.

This level of integration and dedication makes Montu stand out not only in Australia but also on the global stage.

A Workforce Revolution in Healthtech

Montu’s success wouldn’t be possible without its dedicated team of over 850 remote professionals. By fostering a culture of collaboration and innovation, Christopher Strauch has built a workforce well-equipped to handle the rapidly evolving landscape of the medicinal cannabis sector.

Montu’s employee-first environment also makes it an attractive destination for top-tier talent. This has enabled the company to maintain a competitive edge, drive its mission forward, and continually elevate patient care standards.

Advocating for Change

Beyond delivering exceptional healthcare services, Montu actively pushes for legislative and social changes that promote better access to medicinal cannabis. As a founding member of Cannabis Council Australia, the company is actively engaging with policymakers to destigmatise and streamline the use of medical cannabis as a legitimate treatment.

Christopher Strauch and Montu have become powerful advocates for lowering barriers that prevent patients from receiving life-changing therapies, further solidifying their reputation as leaders in the healthcare revolution.

The Visionary Behind Montu

Christopher Strauch’s entrepreneurial spirit and forward-thinking leadership have been instrumental in Montu’s meteoric rise. A firm believer in driving impact through innovation, Christopher anticipates trends and adapts to market shifts with precision.

His leadership emphasises collaboration, fostering a dynamic culture that encourages continuous improvement and prioritises patient needs. This strategy has secured Montu’s position as a global leader in medicinal cannabis, setting a benchmark for the future of healthcare.

Under Christopher’s leadership, Montu continues to expand its influence, not just within Australia but across the globe. By combining technology, education, and cutting-edge healthcare delivery, Montu is creating a legacy that will inspire future entrepreneurs and healthcare leaders alike.

Building a Healthier Future

Montu’s dedication to transforming healthcare is about more than innovation—it’s about making a lasting difference. Through technology, education, and advocacy, Montu is addressing the unique challenges of chronic health conditions while empowering both patients and practitioners with the tools they need for success.

Christopher Strauch’s vision is clear: to enhance wellbeing, one patient at a time. As Montu continues to grow, its impact on the healthtech industry will undoubtedly inspire radical improvements in healthcare around the world.

Christopher Strauch: A Visionary Leader Transforming Healthcare with Montu

Business name(s)help

Business name	From
UMEDS AUSTRALIA	08 Aug 2024
UMEDS GROUP	08 Aug 2024
URMEDS	16 Apr 2024
SAGED MEDICAL CANNABIS WISDOM	26 Mar 2024
CANNABIS COUNCIL AUSTRALIA	06 Nov 2023
Leafio	28 Sep 2023

https://abr.business.gov.au/ABN/View?id=35634198360

Find out more at ASIC